Xencor
Dane Leone currently serves as the Executive Vice President and Chief Strategy Officer at Xencor, a position held since January 2024. Prior to this role, Dane Leone was Managing Director at Raymond James from September 2018 to January 2024 and held the title of Managing Director and Senior Biotech Analyst at BTIG, LLC from July 2014 to July 2018. Earlier experience includes serving as a Research Analyst at Macquarie Bank from January 2010 to June 2014 and at AllianceBernstein from 2005 to 2009. Dane Leone earned a Bachelor's degree in Financial Analysis from the University at Albany between 2000 and 2004.
This person is not in any teams
This person is not in any offices
Xencor
2 followers
Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.